Bør antiprogesteron tas i bruk ved svangerskapsavbrudd?

Tidsskrift for den Norske Laegeforening

Volumn 118, Issue 2, 1998, Pages 212-213

  Iversen, Ole Erik ^a   Bergsjø, Per ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; HORMONE; HORMONE ANTAGONIST; MENSTRUATION INDUCING AGENT; MIFEPRISTONE; MISOPROSTOL; PROGESTERONE RECEPTOR; PROSTAGLANDIN; PROSTAGLANDIN DERIVATIVE;

ABORTION, DRUG INDUCED; ARTICLE; BIOLOGY; CRITIQUE; DEVELOPED COUNTRY; DRUG EFFECT; ENDOCRINE SYSTEM; EUROPE; FAMILY PLANNING; FEMALE; FERTILITY CONTROL, POSTCONCEPTION; HEALTH; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HUMAN; INDUCED ABORTION; NORTHERN EUROPE; NORWAY; OUTPATIENT DEPARTMENT; PHYSIOLOGY; POLITICAL FACTORS; PREGNANCY; RU-486--SIDE EFFECTS; SCANDINAVIA;

ABORTION, DRUG INDUCED; ABORTION, INDUCED; BIOLOGY; CRITIQUE; DELIVERY OF HEALTH CARE; DEVELOPED COUNTRIES; ENDOCRINE SYSTEM; EUROPE; FAMILY PLANNING; FERTILITY CONTROL, POSTCONCEPTION; HEALTH; HEALTH FACILITIES; HORMONE ANTAGONISTS; HORMONES; MISOPROSTOL; NORTHERN EUROPE; NORWAY; OUTPATIENT CLINIC; PHYSIOLOGY; POLITICAL FACTORS; PROSTAGLANDINS; PROSTAGLANDINS, SYNTHETIC; RU-486--SIDE EFFECTS; SCANDINAVIA;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; FEMALE; HUMANS; MENSTRUATION-INDUCING AGENTS; MIFEPRISTONE; PREGNANCY; RECEPTORS, PROGESTERONE;

EID: 0032548317     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Iversen O-E, Nesheim B-I. P-pille som sekundær prevensjon. På tide med reseptfritak? Tidsskr Nor Løgeforen 1994; 114: 662.
2. Ulmann A, Teutsch G, Philibert D. RU 486. Scientific American 1990; 262: 42-8.
3. Creinin MD, Vittinghoff E. Methotrexate and misoprostol vs. misoprostol alone for early abortion: a randomized controlled trial. JAMA 1994; 272: 1190-5.
4. World Health Organization Task Force on postovulatory methods of fertility regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993; 307: 532-7.
5. El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton AA. Induction of abortion with mifepristone (RU 486) and oral or vaginal miso prostol. N Engl J Med 1995; 332: 983-7.
6. Grimes DA. Medical abortion in early pregnancy: a review of the evidence. Obstet Gynecol 1997; 89: 790-6.
7. Roger MW, Baird DT. Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost). Contraception 1989; 40: 439-47.
8. Henshaw RC, Templeton AA. Mifepristone: separating fact from fiction. Drugs 1992; 44: 531-6.
9. Henshaw RC, Naji SA, Russell IT, Templeton AA. Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration: a patient-centered, partially randomized prospective study. Acta Obstet Oynecol Scand 1994; 73: 812-8.
10. Löfgren M, Eriksson L, Ildgruben A, Damber M-G. Medicinsk abort lika bra som kirurgisk. Läkartidningen 1997; 94: 3257-60.
11. Winikoff B. Acceptability of medical abortion in early pregnancy. Fam Plann Perspect 1995; 27: 142-85.
12. Thong KJ, Dewar MH, Baird DT. What do women want during medical abortion? Contraception 1992; 46: 435-42.
13. Henshaw RC, Naji SA, Russel IT, Templeton AA. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment. BMJ 1993; 307: 714-7.
14. St.meld. nr. 16 (1995-96). Om erfaringer med lov om svangerskapsavbrudd mv.: 144-5.
15. Yearbook of Nordic Statistics 1996. Bd. 34. København: Nordisk Ministerråd, 1996: 320.
16. Geirsson RT. A wrong against humanity. Acta Obstet Gynecol Scand 1996; 75: 873-4.